Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Duloxetine in Painful Diabetic Neuropathy
NCT00058968Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of duloxetine in diabetic peripheral neuropathy (DPN), sponsored by Eli Lilly and Company. Started Oct 2002; status: completed.
02
Drugs
duloxetine
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT00058968.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00058968.